Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Perkins

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Psychiatry|September 2, 2025
DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteersYvonne A Bonomo, Amanda F Norman, Lisa Collins, et al.
PLOS Mental Health|February 9, 2026
A new insight into ayahuasca's adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS)Óscar Andión, José Carlos Bouso, Jerome J Sarris, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 18, 2025
Need for closure moderates the relationship between social circle's and own influenza vaccination behavior in a two-wave survey of U.S. adultsJohn D Dimoff, Andillon Del Pesco, Gina M DiLuzio, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 16, 2020
A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy VolunteersDaniel Perkins, Juliet Butler, Katherine Ong, et al.
Psychopharmacology|January 11, 2021
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participantsNicole L Galvão-Coelho, Wolfgang Marx, Maria Gonzalez, et al.
Australian and New Zealand Journal of Public Health|November 8, 2024
Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practiceBianca Sebben, Jem Stone, Jerome Sarris, et al.
Frontiers in Pharmacology|May 10, 2021
Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International SurveyDaniel Perkins, Violeta Schubert, Hana Simonová, et al.
PLOS Global Public Health|March 24, 2023
Adverse effects of ayahuasca: Results from the Global Ayahuasca SurveyJosé Carlos Bouso, Óscar Andión, Jerome J Sarris, et al.
Drug and Alcohol Review|July 26, 2021
Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional surveyDaniel Perkins, Emerita S Opaleye, Hana Simonova, et al.
Scientific Reports|November 20, 2025
Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 studyDaniel Perkins, Andreas Halman, Anna Urokohara, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Psychiatry|September 2, 2025
DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteersYvonne A Bonomo, Amanda F Norman, Lisa Collins, et al.
PLOS Mental Health|February 9, 2026
A new insight into ayahuasca's adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS)Óscar Andión, José Carlos Bouso, Jerome J Sarris, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 18, 2025
Need for closure moderates the relationship between social circle's and own influenza vaccination behavior in a two-wave survey of U.S. adultsJohn D Dimoff, Andillon Del Pesco, Gina M DiLuzio, et al.
European Journal of Drug Metabolism and Pharmacokinetics|May 16, 2020
A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy VolunteersDaniel Perkins, Juliet Butler, Katherine Ong, et al.
Psychopharmacology|January 11, 2021
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participantsNicole L Galvão-Coelho, Wolfgang Marx, Maria Gonzalez, et al.
Australian and New Zealand Journal of Public Health|November 8, 2024
Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practiceBianca Sebben, Jem Stone, Jerome Sarris, et al.
Frontiers in Pharmacology|May 10, 2021
Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International SurveyDaniel Perkins, Violeta Schubert, Hana Simonová, et al.
PLOS Global Public Health|March 24, 2023
Adverse effects of ayahuasca: Results from the Global Ayahuasca SurveyJosé Carlos Bouso, Óscar Andión, Jerome J Sarris, et al.
Drug and Alcohol Review|July 26, 2021
Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional surveyDaniel Perkins, Emerita S Opaleye, Hana Simonova, et al.
Scientific Reports|November 20, 2025
Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 studyDaniel Perkins, Andreas Halman, Anna Urokohara, et al.
Pageof 5